188 related articles for article (PubMed ID: 7675642)
1. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
Seeger T; Emrich D; Sandrock D
Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
[TBL] [Abstract][Full Text] [Related]
2. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine treatment of Plummer's disease.
Moser E
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S63-5. PubMed ID: 9867200
[TBL] [Abstract][Full Text] [Related]
4. [First results of radioiodine therapy of multifocal and disseminated thyroid gland autonomy and use of a TcTUs-adapted dose concept].
Oexle C; Reinhardt M; Moser E
Nuklearmedizin; 1998; 37(6):192-6. PubMed ID: 9770712
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
6. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
[TBL] [Abstract][Full Text] [Related]
8. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
[TBL] [Abstract][Full Text] [Related]
9. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
Glanzmann Ch; Horst W
Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
[TBL] [Abstract][Full Text] [Related]
11. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
Langhammer HR; Laubenbacher C; Hirsch C; Klingele C; Spyra JL; Senekowitsch-Schmidtke R; Schwaiger M
Med Klin (Munich); 1999 Aug; 94(8):415-24. PubMed ID: 10495620
[TBL] [Abstract][Full Text] [Related]
12. [Improved evaluation criteria of autonomous thyroid adenoma: triiodothyronine concentration in serum, functional definition through TRH test].
Wenzel KW; Meinhold H; Schleusener H; Botsch H
Dtsch Med Wochenschr; 1974 Jul; 99(27):1465-73. PubMed ID: 4135676
[No Abstract] [Full Text] [Related]
13. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake.
Kristoffersen US; Hesse B; Rasmussen AK; Kjaer A
Clin Physiol Funct Imaging; 2006 May; 26(3):167-70. PubMed ID: 16640512
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
15. [Function of the thyroid gland following radio-iodine therapy in hyperthyroidism: thyroxine, triiodothyronine and TSH reaction after TRH stimulation].
Pickardt CR; Einhäuser G; Erhardt F; Heinze HG; Horn K; Scriba PC
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1874-7. PubMed ID: 829464
[No Abstract] [Full Text] [Related]
16. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
[No Abstract] [Full Text] [Related]
17. What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Gotthardt M; Rubner C; Bauhofer A; Berce F; Oyen WJ; Goecke J; Pfestroff A; Schlieck A; Corstens FH; Béhé M; Behr TM
Nuklearmedizin; 2006; 45(5):206-12. PubMed ID: 17043731
[TBL] [Abstract][Full Text] [Related]
18. Serum thyrotrophin and response to thyrotrophin-releasing hormone in patients who are euthyroid after radioiodine treatment for hyperthyroidism.
Gordin A; Wägar G; Hernberg A
Acta Med Scand; 1973 Oct; 194(4):335-40. PubMed ID: 4127154
[No Abstract] [Full Text] [Related]
19. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
Reinhardt M; Emrich D; Krause T; Bräutigam P; Nitzsche E; Blattmann H; Schümichen C; Moser E
Eur J Endocrinol; 1995 May; 132(5):550-6. PubMed ID: 7749494
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine treatment of hyperthyroidism in a pregnant women.
Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
